Cargando…
A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma
This is a case of a middle-aged woman with underlying cardiac conduction system with episodes of AV Wenckebach, who subsequently developed significant AV conduction system abnormalities after receiving one standard dose of Rituximab infusion for diffuse large B-cell lymphoma. Rituximab, being a mono...
Autores principales: | Ko Ko, Nway Le, Minaskeian, Nareg, El Masry, Hicham Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552504/ https://www.ncbi.nlm.nih.gov/pubmed/33062307 http://dx.doi.org/10.1186/s40959-020-00077-5 |
Ejemplares similares
-
Combined endocardial and epicardial ablation of drug-refractory ventricular tachycardia by direct ventricular puncture
por: Ashraf, Hasan, et al.
Publicado: (2021) -
Primary breast diffuse large B-cell lymphoma in the era of rituximab
por: Zhang, Na, et al.
Publicado: (2016) -
Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis
por: Zhou, Xuan, et al.
Publicado: (2017) -
Subcutaneous Rituximab in Follicular Lymphoma, Chronic Lymphocytic Leukemia, and Diffuse Large B-Cell Lymphoma
por: Yelvington, Bradley J.
Publicado: (2018) -
Left Atrial Myxomectomy with Intraoperative Severe Mitral Regurgitation and Complicated Postoperative Course – Case Report
por: Minaskeian, Nareg, et al.
Publicado: (2016)